FindTrial
Sign In

Study of the efficacy of prophylactic high-flow oxygen therapy after bronchial surgery in patients with silicosis

Study of the efficacy of prophylactic high-flow oxygen therapy after bronchial surgery in patients with silicosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101239
Enrollment
Unknown
Registered
2025-04-22
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxemia after bronchial surgery

Interventions

High-Flow Oxygen Consumption Cohort (HFNC Cohort):High-Flow Oxygen
Conventional oxygen therapy group (COT group):Double-lumen nasal cannula for oxygen

Sponsors

Quanzhou first Hospital,Fujian
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.- Patients diagnosed with silicosis; 2.- American Society of Anesthesiologists (ASA) classification I-III; 3.- Undergoing bronchial surgical treatment under general anesthesia intubation and transferred to the general ward after surgery; 4.- Be over 18 years of age and have full civil capacity; 5.- Voluntarily participated in this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1.- Contraindications to surgery; 2.- Severe hypertension or cardiac disease; 3.- Severe hepatic or renal dysfunction; 4.- Inability to tolerate high-flow oxygen devices.

Design outcomes

Primary

MeasureTime frame
Oximetry;Postoperative pulmonary complications;—

Countries

China

Contacts

Public Contactsun jiaxiao

Quanzhou first Hospital,Fujian

leonkillua@163.com+86 15859491198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026